Αποτελέσματα Αναζήτησης
2 Οκτ 2020 · For patients with uncomplicated deep vein thrombosis (DVT), the American Society of Hematology (ASH) guideline panel suggests offering home treatment over hospital treatment (conditional recommendation based on low certainty in the evidence of effects ⨁⨁ ).
- Duration of anticoagulant therapy for deep vein thrombosis and ...
It takes about 3 months to complete “active treatment” of...
- Duration of anticoagulant therapy for deep vein thrombosis and ...
27 Νοε 2018 · The recommendation places a high value on avoiding the uncertainty in DOAC anticoagulant response associated with coadministration of the interacting drug and a low value on avoiding the burden of warfarin or LMWH therapy.
12 Αυγ 2024 · In treating DVT, the main goal is to prevent the clot from getting bigger and to prevent it from breaking off to cause a pulmonary embolus (PE). Other goals of treatment include preventing the clot from becoming larger, preventing new blood clots from forming, and preventing long-term complications. The treatment of DVT and PE are similar.
3 Σεπ 2024 · Deep vein thrombosis (DVT) and pulmonary embolism (PE) are forms of venous thromboembolism (VTE). VTE has significant morbidity and mortality for patients in the community and in hospital. Anticoagulation is the mainstay of therapy for VTE.
20 Μαρ 2014 · It takes about 3 months to complete “active treatment” of venous thromboembolism (VTE), with further treatment serving to prevent new episodes of thrombosis (“pure secondary prevention”). Consequently, VTE should generally be treated for either 3 months or indefinitely (exceptions will be described in the text).
18 Δεκ 2020 · Clinical pathways are suggested for four potential clinical situations: (1) prior AF on anticoagulation and the need for PCI; (2) new-onset AF requiring anticoagulation in a patient already on antiplatelet therapy for coronary artery disease (CAD); (3) prior VTE on anticoagulation and the need for PCI; and (4) new or recurrent VTE requiring ...
2 Αυγ 2021 · In patients with VTE (DVT of the leg or PE) we recommend apixaban, dabigatran, edoxaban, or rivaroxaban over vitamin K antagonist (VKA) as treatment-phase (first 3 months) anticoagulant therapy (strong recommendation, moderate-certainty evidence).
